XM अमेरिका के निवासियों को अपनी सेवाएँ मुहैया नहीं करता है।
R
R

Resmed


समाचार

U.S. Amerant Bancorp, BlackRock, Equinix

U.S. RESEARCH ROUNDUP-Amerant Bancorp, BlackRock, Equinix Oct 1 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Amerant Bancorp, BlackRock and Equinix, on Tuesday. HIGHLIGHTS * Amerant Bancorp Inc AMTB.N : Stephens raises to overweight from equal-weight * BlackRock BLK.N : JP Morgan raises target price to $864 from $774 * Equinix Inc EQIX.O : JP Morgan raises target price to $975 from $950 * Interpublic Group of Comp
A
P
C
L
R

Resmed Unveils New Five-Year Financial Outlook

BRIEF-Resmed Unveils New Five-Year Financial Outlook Sept 30 (Reuters) - Resmed Inc RMD.N : RESMED UNVEILS 2030 STRATEGY TO DRIVE GROWTH, PROFITABILITY, AND SHAREHOLDER RETURNS RESMED: NEW FIVE-YEAR FINANCIAL OUTLOOK INCLUDES HIGH-SINGLE-DIGIT REVENUE GROWTH RESMED: NEW FIVE-YEAR FINANCIAL OUTLOOK INCLUDES EARNINGS GROWTH HIGHER THAN REVENUE GROWTH
R

S&P 500 top and bottom performing stocks at about 03:30 p.m. EDT

BUZZ - S&P 500 top and bottom performing stocks at about 03:30 p.m. EDT S&P 500 .SPX Top Performers Percent Change West Pharmaceutical Services Inc WST.N +4.9% Dollar Tree Inc DLTR.OQ +3.3% Bio Rad Laboratories Inc BIO.N +3.2% Bath & Body Works Inc BBWI.N +3.2% General Motors Co GM.N +3.2% Bottom Performers Percent Change Resmed Inc RMD.N -4.8% Ave
D
D
T
U
A
R

U.S. STOCKS United States Steel, Ambac Financial, Apple

BUZZ-U.S. STOCKS ON THE MOVE-United States Steel, Ambac Financial, Apple Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 Wall Street's main indexes slipped in volatile trading on Wednesday ahead of the Federal Reserve's highly anticipated first interest rate cut in more than four years, with jitters over the magnitude of the reduction dominating mood.
A
B
C
G
M
N
S
U
U
U
R

U.S. STOCKS Powerfleet, NMI, Vivos Therapeutics

BUZZ-U.S. STOCKS ON THE MOVE-Powerfleet, NMI, Vivos Therapeutics Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 Wall Street's main indexes were flat on Wednesday as investors stepped onto the sidelines ahead of the Federal Reserve's highly anticipated first interest rate cut in more than four years, with bets favoring a 50-basis-point reduction.
B
G
M
N
U
C
U
U
R

ResMed falls as Wolfe Research downgrades to 'underperform' on 1 risks

BUZZ-ResMed falls as Wolfe Research downgrades to 'underperform' on GLP-1 risks ** Shares of medical device maker ResMed RMD.N fall 6.1% to $235.65 ** Brokerage Wolfe Research downgrades to "underperform" from "peer perform", sets PT of $180 * Expect significant risk of disruption in patient demand next year as FDA likely to approve Eli Lilly's LLY
U
R

KeyBanc says sleep apnea device makers to benefit from new Apple Watch feature

BUZZ-KeyBanc says sleep apnea device makers to benefit from new Apple Watch feature ** Brokerage KeyBanc Capital Markets says it views the news of Apple AAPL.O launching sleep apnea detection in its new Watch Series 10, and existing Watch Series 9 and Watch Ultra 2 as positive for medical device makers Resmed RMD.N and Inspire Medical Systems INSP.
A
G
R

U.S. STOCKS Lumen Technologies, Insulet, PDD Holdings

BUZZ-U.S. STOCKS ON THE MOVE-Lumen Technologies, Insulet, PDD Holdings Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 The S&P 500 rose on Tuesday in mixed trading ahead of a highly anticipated quarterly report from Nvidia and economic data expected later in the week.
N
W
U
U
C
M
R

U.S. STOCKS Eli Lilly, JD.com, Super Micro Computer

BUZZ-U.S. STOCKS ON THE MOVE-Eli Lilly, JD.com, Super Micro Computer Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 Wall Street's main indexes were lower on Tuesday, weighed down by tech-related stocks, as caution prevailed ahead of a highly anticipated earnings report from Nvidia and crucial economic data expected later in the week.
N
U
U
C
M
R

Resmed Expands Board By Appointing Christopher Delorefice

BRIEF-Resmed Expands Board By Appointing Christopher Delorefice Aug 15 (Reuters) - Resmed Inc RMD.N : RESMED EXPANDS ITS BOARD OF DIRECTORS AND APPOINTS HEALTHCARE EXECUTIVE AND SEASONED FINANCE LEADER CHRISTOPHER DELOREFICE TO ITS BOARD Source text for Eikon: ID:nGNX7KRqxN Further company coverage: RMD.N
R

Australia shares slump more than 3% as US recession worries trigger sell-off

Australia shares slump more than 3% as US recession worries trigger sell-off ASX 200 posts worst session since June 2022 ASX volatility index at more than 2-year high Tech stocks lose 6.6%, financials drop 5% RBA policy decision due on Tuesday Updates to close By Himanshi Akhand and Rajasik Mukherjee Aug 5 (Reuters) - Australian shares slumped more than 3% in their worst trading session in over two years on Monday, joining a global sell-off in riskier assets after weak U.S.
A
R

Australia-listed shares of ResMed climb to 1-year high as analysts hike PT

BUZZ-Australia-listed shares of ResMed climb to 1-year high as analysts hike PT ** ASX-listed shares of ResMed RMD.AX RMD.N rise as much as 7% to A$34.020, their highest since Aug 2, 2023 ** Analysts at J.P. Morgan lift their price target on the medical equipment maker to A$37 from A$34.5 after its quarterly results ** Macquarie analysts raise PT to A$36.25 from A$35.40 ** U.S.-based co on Friday reported adj.
R

Resmed Inc reports results for the quarter ended in January - Earnings Summary

Resmed Inc reports results for the quarter ended in January - Earnings Summary Resmed Inc RMD.N reported quarterly adjusted earnings of $2.08​​ per share for the quarter ended in January, higher than the same quarter last year, when the company reported EPS of $1.60. The mean expectation of twelve analysts for the quarter was for earnings of $2.07 per share.
R

Resmed Inc reports results for the quarter ended in June - Earnings Summary

Resmed Inc reports results for the quarter ended in June - Earnings Summary Resmed Inc RMD.N reported quarterly adjusted earnings of $2.08​​ per share for the quarter ended in June, higher than the same quarter last year, when the company reported EPS of $1.60. The mean expectation of twelve analysts for the quarter was for earnings of $2.07 per share.
R

ResMed meets estimates on steady demand for its sleep apnea devices

ResMed meets estimates on steady demand for its sleep apnea devices Aug 1 (Reuters) - Medical equipment maker ResMed RMD.N reported fourth-quarter revenue in line with estimates on Thursday, on steady demand for its sleep apnea treatment devices. The company's quarterly revenue rose 9% to $1.22 billion, in line with estimates of $1.22 billion. ResMed makes ventilators and machines that provide continuous and bilateral positive airway pressure, known as CPAP and BIPAP, which are used for non-inva
R

Resmed Q4 Adjusted EPS USD 2.08 Vs. IBES Estimate USD 2.07

BRIEF-Resmed Q4 Adjusted EPS USD 2.08 Vs. IBES Estimate USD 2.07 Aug 01 (Reuters) - Resmed Q4 EPS USD 1.98. Q4 revenue USD 1,200 million vs. IBES estimate USD 1,217 million Q4 adjusted gross margin 59.1% Q4 gross margin 58.5%
R

Resmed Inc <RMD.N> expected to post earnings of $2.07 a share - Earnings Preview

Resmed Inc expected to post earnings of $2.07 a share - Earnings Preview Resmed Inc RMD.N , RMD is expected to show a rise in quarterly revenue when it reports results on August 1 for the period ending June 30 2024 The San Diego California-based company is expected to report a 8.4% increase in revenue to $1.217 billion from $1.12 billion a year ago, according to the mean estimate from 13 analysts, based on LSEG data.
R

S&P 500 top and bottom performing stocks at about 03:30 p.m. EDT

BUZZ - S&P 500 top and bottom performing stocks at about 03:30 p.m. EDT S&P 500 .SPX Top Performers Percent Change ON Semiconductor Corp ON.OQ +12.2% Revvity Inc RVTY.N +8.7% Resmed Inc RMD.N +5.5% Tesla Inc TSLA.OQ +4.9% McDonald's Corp MCD.N +4.2% Bottom Performers Percent Change Enphase Energy Inc ENPH.OQ -5.2% Southwest Airlines Co LUV.N -3.3%
T
O
U
E
G
R

S&P 500 top and bottom performing stocks at about 12:00 p.m. EDT

BUZZ - S&P 500 top and bottom performing stocks at about 12:00 p.m. EDT S&P 500 .SPX Top Performers Percent Change ON Semiconductor Corp ON.OQ +13.3% Dexcom Inc DXCM.OQ +6.2% Revvity Inc RVTY.N +5.5% Resmed Inc RMD.N +4.7% Tesla Inc TSLA.OQ +4.6% Bottom Performers Percent Change Constellation Brands Inc STZ.N -3.0% Franklin Resources Inc BEN.N -2.7
T
W
O
U
D
R

U.S. STOCKS Hartford Financial, Avantor, WesBanco

BUZZ-U.S. STOCKS ON THE MOVE-Hartford Financial, Avantor, WesBanco Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 Wall Street bounced back on Friday with the blue-chip Dow leading the charge as some megacap tech and chip stocks recovered from the week's pummeling, while a largely in-line key inflation reading kept bets of an early rate cut alive.
B
B
C
G
N
U
U
A
M
R



स्थितियाँ

लोकप्रिय परिसंपत्तियाँ

अस्वीकरण: XM Group के सत्व केवल निष्पादन वाली सेवा और हमारी ऑनलाइन व्यापार सुविधा में पहुँच प्रदान करते हैं, ताकि व्यक्ति वेबसाइट पर या उसके जरिए उपलब्ध सामग्री को देख सके और/या उसका उपयोग कर सके। इसका प्रयोजन इसे बदलना या विस्तार देना नहीं है, न ही वह इसे बदलता या विस्तार देता है। इस तरह की पहुँच हमेशा ही निम्नलिखित के अधीन रहेगी: (1) नियम और शर्तें; (2) जोखिम चेतावनियाँ; और (3) पूर्ण अस्वीकरण। इसलिए ऐसी जानकारी सामान्य सूचना से अधिक कुछ भी नहीं है। विशेष रूप से, कृपया इससे अवगत रहें कि हमारी ऑनलाइन व्यापार सुविधा की सामग्रियाँ न तो किसी चीज का अनुरोध करती हैं, न ही वित्तीय बाजारों में प्रवेश करने की पेशकश ही करती हैं। किसी भी वित्तीय बाजार में व्यापार करने के साथ आपकी पूँजी को उल्लेखनीय जोखिम है।

हमारी ऑनलाइन व्यापार सुविधा में प्रकाशित सभी सामग्रियाँ शैक्षणिक/सूचनात्मक प्रयोजनों मात्र के लिए हैं, और इनमें वित्तीय, निवेश टैक्स या व्यापार सलाह और सुझाव नहीं हैं - न ही ऐसा समझना चाहिए कि इनमें ये सब हैं; न ही इनमें हमारी व्यापार कीमतों का अभिलेख है; न ही इनमें किसी वित्तीय उपकरण में लेन-देन करने का निमंत्रण या अनुरोध है; न ही ये आपको अवांछित वित्तयी प्रोमोशन पेश करती हैं।

इस वेबसाइट में मौजूद कोई भी तृतीय पक्षीय सामग्री, तथा XM द्वारा तैयार की गई सामग्रियाँ, जैसे: अभिप्राय, समाचार, अनुसंधान, विश्लेषण, कीमतें और अन्य सूचनाएँ या तृतीय पक्षों की साइटों के लिंक, "जैसा-है-वैसा" के आधार पर बाजार के बारे में सामान्य टिप्पणी के रूप में उपलब्ध कराई गई हैं, और वे निवेश हेतु सलाह नहीं हैं। जिस हद तक कीसी सामग्री को निवेश अनुसंधान मान लिया जाता है, उस हद तक आपको ध्यान में रखना होगा और इसे स्वीकार करना होगा कि वह सामग्री इस उद्देश्य से और निवेश अनुसंधान की स्वतंत्रता को बढ़ावा देने के लिए कानूनी आवश्यकताओं के मुताबिक, तैयार नहीं की गई है, और इसलिए उसे प्रासंगिक कानूनों और विनियमों के तहत विपणन संप्रेषण माना जाएगा। कृपया सुनिश्चित करें कि आपने गैर-आश्रित निवेश के बारे में हमारी सूचना को पढ़ और समझ लिया है। पीछे दी गई जानकारी के बारे में अनुसंधान और जोखिम चेतावनी यहाँ उपलब्ध है।

जोखिम की चेतावनी: आपकी पूँजी जोखिम में है। लीवरेज वाले उत्पाद सबके उपयुक्त नहीं होते हैं। कृपया हमारे जोखिम खुलासे पर विचार करें।